ArticleClinical and experimental medicine2025
Analysis of the effectiveness and safety of lenvatinib/bevacizumab combined with PD-1/PD-L1 inhibitors and GEMOX in the first-line treatment of advanced biliary tract carcinoma.
Lu Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.